Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 23.2.2024TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3383AEplerenone Teva 50 mg (tbl flm 90x1x50 mg (blis.PVC/PVDC/Al perf.))23.2.2024O
 23.2.2024MEDOCHEMIE Ltd. (MOE)0324DSOFENTIL 5 mikrogramov/ml injekčný/infúzny roztok (sol ijf 5x10 ml (amp.skl.))19.2.2024R
 23.2.2024MEDOCHEMIE Ltd. (MOE)0893CSiranalen 75 mg tvrdé kapsuly (cps dur 84x75 mg (blis.PVC/PVDC/Al))19.2.2024O
 23.2.2024MEDOCHEMIE Ltd. (MOE)2851CONYCHOMED 250 mg (tbl 56x250 mg (blis.PVDC/Al))15.3.2024Z
 23.2.2024MEDOCHEMIE Ltd. (MOE)37109ARKETIS 30 mg (tbl 30x30 mg (blis.PVC/Al))19.2.2024R
 23.2.2024MEDOCHEMIE Ltd. (MOE)5231BAXETINE 250 mg (tbl flm 10x250 mg (blis.Al/Al))21.2.2024R
 23.2.2024MEDOCHEMIE Ltd. (MOE)6341ASULCEF 2 g (plo ijf 10x2 g (liek.inj.skl.))19.2.2024R
 23.2.2024MEDOCHEMIE Ltd. (MOE)65114MEDOCLAV 1,2 g (plo ijf 100x1,2 g (liek.inj.skl.))19.2.2024O
 23.2.2024MEDOCHEMIE Ltd. (MOE)67015GYRABLOCK 400 mg (tbl flm 14x400 mg (fľ.PE))14.2.2024Z
 23.2.2024MEDOCHEMIE Ltd. (MOE)67561Dapril 5 mg (tbl 30x5 mg (blis.PVC/PVDC/Al))14.2.2024Z
 23.2.2024MEDOCHEMIE Ltd. (MOE)67562Dapril 10 mg (tbl 30x10 mg (blis.PVC/PVDC/Al))14.2.2024Z
 23.2.2024MEDOCHEMIE Ltd. (MOE)7243CTAXIMED 2 g (plo ijf 10x2 g (liek.inj.skl.))19.2.2024O
 23.2.2024MEDOCHEMIE Ltd. (MOE)7672BSAGILIA 1mg tablety (tbl 28x1 mg (blis.PVC/PE/PVDC/Al))19.2.2024R
 23.2.2024Mundipharma Corporation (Ireland) Limited (MUP-IE-1)9765CPelmeg 6 mg injekčný roztok naplnený v injekčnej striekačke (sol inj 1x0,6 ml/6 mg (striek.inj.napl.skl.))23.2.2024R
 22.2.2024Bayer, spol. s r.o. (BAY-SK-2)96230ASPIRIN C (tbl eff 20x400 mg/240 mg (strip papier/PE/Al/Surlyn))22.2.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)